Skip to main content

Understanding how Vyvanse works to treat Binge-Eating Disorder

Do you binge-eat at least 3 days a week or are you distressed about your binge eating?

If you have answered yes to these questions, you may be eligible to participate in a clinical trial looking at how the medication Vyvanse works to reduce binge-eating symptoms.

The trial runs for 8 weeks and you would need to:
- Attend Westmead Institute for Medical Research & Westmead Hospital twice (before medication and after 8 weeks of medication) to complete interviews, questionnaires, cognitive tests, and brain scans.
- Have a blood pressure check at week 2, at Westmead or by your GP.
- Have a doctors appointment at Westmead Hospital at week 4, to check your medication dose.

During the trial, you would not be able to use any other treatments for your binge-eating symptoms. 

Ethics approval # HREC/17/WMEAD/490.


You may be eligible to participate in this study if you:

  • Are 18-40 years old
  • Have a moderate to severe Binge-Eating Disorder
  • Have a Body Mass Index of 20 – 45kg/m2

Please contact the research team who will discuss the full eligibility criteria with you.

How to participate

If you are interested in assisting with this important and exciting area of research, please contact Jenny via email or phone: 8627 3321.